SAN DIEGO, June 13, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (NASDAQ: TEM ) common ...

Crain's lists of the highest-paid CEOs and non-CEOs in the Chicago area are back for 2025, with new names at the top of both ...

AI their business, with some of them mobilizing chatbots and robotics to speed up productivity, according to a recent survey.

Basket, an AI-powered shopping assistant backed by BrewDog co-founder James Watt, is looking to crowdfund £2m to help roll ...

The IPO market remains frozen in 2025, keeping startups like Kin and M1 in limbo. Here’s why deals are stalled—and what that ...

Shares of Tempus AI Inc (NASDAQ:TEM) surged 15% on Monday, recovering some of last week’s sharp losses after a short-seller report from Spruce Point Capital triggered a 13% weekly drop. The rebound ...

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a groundbreaking initiative set to transform precision medicine.

TheStreet. On May 28, Tempus AI stock plunged as the market reacted to a damning report from short seller Spruc ...

An independent safety board has endorsed the continuation of BioXcel Therapeutics, Inc.'s (NASDAQ: BTAI) pivotal Phase 3 SERENITY At-Home trial evaluating BXCL501 for agitation tied to bipolar ...

Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's closing price on Tuesday (the day before Spruce Point released its report), ...

The concept of AI in healthcare is no longer a novelty, experts are acknowledging AI algorithms, detection, and drug discovery are ...